Document type: drug_safety_update
There are 841 pages with document type ‘drug_safety_update’ in the GOV.UK search index.
Rendering apps
This document type is rendered by:
Supertypes
| Type | Group |
|---|---|
| User journey | thing |
| Email document type | other |
| Government document type | other |
| Content Purpose Subgroup | updates_and_alerts |
| Content Purpose Supergroup | news_and_communications |
Content schemas
This document type is allowed by the schema:
Example pages
- GLP-1 receptor agonists: reminder of the potential side effects and to be aware of the potential for misuse
- Valproate (Belvo, Convulex, Depakote, Dyzantil, Epilim, Epilim Chrono or Chronosphere, Episenta, Epival, and Syonell▼): review by two specialists is required for initiating valproate but not for male patients already taking valproate
- GLP-1 and dual GIP/GLP-1 receptor agonists: potential risk of pulmonary aspiration during general anaesthesia or deep sedation
- Topiramate (Topamax): introduction of new safety measures, including a Pregnancy Prevention Programme
- Valproate use in men: as a precaution, men and their partners should use effective contraception
- Finasteride: reminder of the risk psychiatric side effects and of sexual side effects (which may persist after discontinuation of treatment)
- Fluoroquinolone antibiotics: must now only be prescribed when other commonly recommended antibiotics are inappropriate
- Fluoroquinolone antibiotics: reminder of the risk of disabling and potentially long-lasting or irreversible side effects
- Quinine: not to be used routinely for nocturnal leg cramps
- Metformin and reduced vitamin B12 levels: new advice for monitoring patients at risk